FFA
RIGL icon

Farther Finance Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Farther Finance Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.1K Buy
897
+145
+19% +$4.47K ﹤0.01% 3533
2026
Q1 		$20.7K Sell
752
-20
-3% -$672 ﹤0.01% 3630
2025
Q4 		$33.1K Buy
772
+42
+6% +$1.58K ﹤0.01% 3092
2025
Q3 		$20.7K Buy
730
+8
+1% +$239 ﹤0.01% 3021
2025
Q2 		$13.5K Buy
722
+27
+4% +$512 ﹤0.01% 2914
2025
Q1 		$11.9K Buy
695
+28
+4% +$568 ﹤0.01% 2654
2024
Q4 		$11.2K Hold
667
– – ﹤0.01% 2341
2024
Q3 		$10.8K Buy
+667
New +$7.84K ﹤0.01% 2334

Other funds holding RIGL

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors's RIGL Position: Q2 2026 in Review

Farther Finance Advisors increased its Rigel Pharmaceuticals (RIGL) stake by 19% in Q2 2026, buying an estimated $4.47K and bringing the position to 897 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3533.

Farther Finance Advisors first reported a position in RIGL in Q3 2024 and has held it in 8 quarters since. 7 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Farther Finance Advisors held 897 shares of Rigel Pharmaceuticals worth $35.1K as of Q2 2026.
  • Farther Finance Advisors bought 145 Rigel Pharmaceuticals shares in Q2 2026, an estimated $4.47K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3533 holding.
  • Farther Finance Advisors first reported a position in Rigel Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 7 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.